Comparison between Bio Medica Laboratories IPO and Logiciel Solutions IPO.
Bio Medica Laboratories IPO is a SME Bookbuilding IPO proposed to list at NSE SME while Logiciel Solutions IPO is a SME Bookbuilding proposed to list at BSE SME.
| Bio Medica Laboratories IPO | Logiciel Solutions IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Bookbuilding |
| Listing At | NSE SME | BSE SME |
| Lead Managers | Narnolia Financial Services Ltd. | Fintellectual Corporate Advisors Pvt.Ltd. |
| Registrar | Skyline Financial Services Pvt.Ltd. | Maashitla Securities Pvt.Ltd. |
| Market Maker | Prabhat Financial Services Ltd. | Prabhat Financial Services Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | ||
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Bio Medica Laboratories IPO is up to ₹49.80 Cr whereas the issue size of the Logiciel Solutions IPO is up to ₹37.90 Cr. The final issue price of Bio Medica Laboratories IPO is ₹139.00 per share and of Logiciel Solutions IPO is ₹193.00 per share.
| Bio Medica Laboratories IPO | Logiciel Solutions IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹132.00 per share | ₹183.00 per share |
| Issue Price (Upper) | ₹139.00 per share | ₹193.00 per share |
| Issue Price (Final) | ₹139.00 per share | ₹193.00 per share |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | 1000 shares | 600 shares |
| Fresh Issue Size | 32,06,000 shares | 15,90,600 shares |
| Fresh Issue Size (Amount) | up to ₹44.56 Cr | up to ₹30.70 Cr |
| OFS Issue Size | 3,77,000 shares | 3,73,200 shares |
| OFS Issue Size (Amount) | up to ₹5.24 Cr | up to ₹7.20 Cr |
| Issue Size Total | 35,83,000 shares | 19,63,800 shares |
| Issue Size Total (Amount) | up to ₹49.80 Cr | up to ₹37.90 Cr |
Bio Medica Laboratories IPO opens on May 21, 2026, while Logiciel Solutions IPO opens on Nov 28, 2025. The closing date of Bio Medica Laboratories IPO and Logiciel Solutions IPO is May 25, 2026, and Dec 02, 2025, respectively.
| Bio Medica Laboratories IPO | Logiciel Solutions IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | May 21, 2026 | Nov 28, 2025 |
| Issue Close | May 25, 2026 | Dec 02, 2025 |
| Basis Of Allotment (Tentative) | May 26, 2026 | Dec 03, 2025 |
| Initiation of Refunds (Tentative) | May 27, 2026 | Dec 04, 2025 |
| Credit of Share (Tentative) | May 27, 2026 | Dec 04, 2025 |
| Listing date (Tentative) | May 29, 2026 | Dec 05, 2025 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Bio Medica Laboratories IPO P/E ratio is 13.03, as compared to Logiciel Solutions IPO P/E ratio of 20.35.
| Bio Medica Laboratories IPO | Logiciel Solutions IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated)
| Company Financials (Restated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 96.84 | 82.78 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 59 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 13.03 | 20.35 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹174.79 Cr. | ₹144.13 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 99.59 | 32.80 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 48.20 | 31.95 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 1.02 | 0.00 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹10.67 | ₹9.48 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 99.59 | 32.80 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Bio Medica Laboratories IPO Retail Individual Investors (RII) are offered 17,92,000 shares while in Logiciel Solutions IPO retail investors are offered 17,92,000 shares. Qualified Institutional Buyers (QIB) are offered 36,000 shares in Bio Medica Laboratories IPO and 1,00,200 shares in Logiciel Solutions IPO.
| Bio Medica Laboratories IPO | Logiciel Solutions IPO | |
|---|---|---|
| Anchor Investor Reservation | 0 shares | 0 shares |
| Market Maker Reservation | 1,89,000 shares | 1,03,800 shares |
| QIB | 36,000 shares | 1,00,200 shares |
| NII | 17,55,000 shares | 9,28,800 shares |
| RII | 17,92,000 shares | 9,34,800 shares |
| Employee | 0 shares | 0 shares |
| Others | ||
| Total | 35,83,000 shares | 19,63,800 shares |
Bio Medica Laboratories IPO subscribed 2.26x in total, whereas Logiciel Solutions IPO subscribed 2.04x.
| Bio Medica Laboratories IPO | Logiciel Solutions IPO | |
|---|---|---|
| QIB (times) | 15.94x | 1.32x |
| NII (times) | 1.30x | 0.73x |
| Big NII (times) | 0.86x | 0.43x |
| Small NII (times) | 2.19x | 1.32x |
| RII (times) | 2.92x | 3.43x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 2.26x | 2.04x |
